Botulinum Toxin
Neurotoxin (SNARE cleaver)
Bacterial neurotoxin from Clostridium botulinum that cleaves SNARE proteins, blocking acetylcholine release; used in neuromuscular research.
Evidence level. Published human clinical data exists, from trials or approved use. About the badges
- Class
- Neurotoxin (SNARE cleaver)
- Category
- Skin, Hair & Cosmetic
- Type
- Single compound
- Development and regulatory status
- Approved medicines exist (e.g. onabotulinumtoxinA); catalogue item is research material
What researchers study
Botulinum toxin is a bacterial protein neurotoxin from Clostridium botulinum. It cleaves SNARE proteins such as SNAP-25 inside nerve terminals, blocking acetylcholine release at the neuromuscular junction.
Research areas
- SNARE protein cleavage and exocytosis assays
- Neuromuscular junction transmission studies
- Neuronal cell-signalling and pain-pathway models
- Skin and nerve regeneration signalling
Reported findings
Summaries of published results. Each one is tagged with the type of study behind it. They describe research outcomes and are not claims about any product. Why study type matters.
- review
Reviews describe type A toxin acting through canonical SNARE cleavage, with further proposed effects on gene regulation, nerve and skin regeneration, vascular signalling and pain pathways
- review
Preclinical studies show a type E formulation has faster onset and shorter neuromuscular effect than type A, partly attributed to SNAP-25 cleavage differences
Studied alongside
Compounds that appear together in research because their mechanisms complement each other, or as comparators. The reasons given are research reasoning, not recommendations for use.
